摘要
慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是目前世界上常见和导致老年患者死亡的重要疾病之一,以持续气流受限、不可逆性慢性气道阻塞为特征,易导致多种并发症及伴随症状,极大地影响了个人生活质量,加重家庭及社会的经济负担。肺栓塞为COPD合并症之一,可导致肺血液循环及呼吸衰竭,有极高的死亡风险。但因其临床症状与COPD急性加重期症状重叠,缺乏特异的临床表现及实验室检查,易被误诊和忽略,从而延误患者治疗,影响预后。本文将从COPD合并肺栓塞的临床诊疗方面进行阐述,为早期识别COPD合并肺栓塞患者及病情严重程度提供一定价值。
Chronic obstructive pulmonary disease(COPD)is one of the most common and important diseases leading to the death of elderly patients in the world at present.It is characterized by continuous airflow restriction and irreversible chronic airway obstruction,which can easily lead to a variety of complications and accompanying symptoms,greatly affecting the quality of life of individuals and increasing the economic burden of families and society.Pulmonary embolism is one of the complications of COPD,which can lead to pulmonary blood circulation and respiratory failure,with a high risk of death.However,because its clinical symptoms overlap with the symptoms of acute exacerbation of COPD and lack of specific clinical manifestations and laboratory tests,it is easy to be misdiagnosed and ignored,thus delaying the treatment of patients and affecting the prognosis.This article will elaborate on the clinical diagnosis and treatment of COPD combined with pulmonary embolism,providing certain value for ear-ly identification of COPD patients combined with pulmonary embolism and the severity of the condition.
作者
王丽芳
李琪
周向东
WANG Li-fang;LI Qi;ZHOU Xiang-dong(Department of Respiratory Medicine,the First Affiliated Hospital of Hainan Medical University,Haikou 570102,China;Clinical Medical Center for Respiratory Diseases,Haikou 570100,China;Key Laboratory of Tropical Disease Control and Prevention,National Health and Health Commission of Hainan Medical University,Haikou 571199,China)
出处
《海南医学院学报》
CAS
北大核心
2024年第2期148-154,160,共8页
Journal of Hainan Medical University
基金
国家重点研发计划(2022YFC2305004)
海南省重点研发项目(ZDYF2020223)
海南省重大科技计划项目(ZDKJ2021036)
海南省重点研发计划国际科技合作项目(GHYF2022011)
国家自然科学基金资助项目(82260001,82160012)。